Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:OPHT
Raised
Post IPO Valuation

General Information

Websiteophthotech.com
CategoryBioTech
Phone(609) 945-6050
Employees
Founded2007

Offices

Princeton, USA
5 Vaughn Drive
Suite 106
Princeton, NJ, 08540
USA
New York, USA
One Penn Plaza
35th Floor
New York, NY, 10119
USA

People

Co-founder and President, Vice Chairman, Board of Directors
Chief Executive Officer, Board of Director
Chief Operating Officer
SVP, Global Regulatory Affairs
Vice President, Finance and Operations
Vice President, Project Management
Board of Director
Board of Director
Show All People

Funding

TOTAL $247M
FUNDING TOTAL $205M
Series B, 12/2009
SV Life Sciences
Novo A/S
HBM BioVentures
Clarus Ventures
$30M
Private Equity, 5/2013
Novo A/S
$125M
Private Equity, 5/2013
Novo A/S
$50M
POST IPO FUNDING TOTAL $41.7M
Post IPO Equity, 1/2014
Novo A/S
$41.7M

Tags

Ophthotech

Ophthotech Corporation, a biopharmaceutical company, develops various therapeutics to treat diseases of the eye. It is developing Fovista, which has completed Phase IIb clinical trials for use in combination with anti-VEGF drugs for the treatment of wet age-related macular degeneration (wet AMD); and ARC1905, a potent and selective inhibitor of complement factor C5 that has completed Phase I/IIa clinical trials to treat wet AMD. The company was founded in 2007 and is headquartered in New York, New York.

Recent Milestones

Videos

Screenshots

Ophthotech screenshot
Above: Home Page
Uploaded: 12/16/09

Stock Price

Sources

  1. Ophthotech nabs $30M round to fund AMD trial (fiercebiotech.com) [edit]
  2. Ophthotech Raises $175 Mln (pehub.com) [edit]
  3. Ophthotech Raises $175 Mln (pehub.com) [edit]
  4. Ophthotech Corporation Receives $41.7 Million in Second Tranche in Royalty Financing from Novo A/S (bioportfolio.com) [edit]
  5. Ophthotech eyes $85M IPO to fund PhIII for drug to prevent blindness (fiercebiotech.com) [edit]
    Ophthotech raises $167.2m in IPO for AMD drug Fovista (bioportfolio.com) [edit]
Edit This Page
Last Edited 2/11/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy